Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$81.45
-2.8%
$87.17
$74.51
$94.80
$37.25B1.133.03 million shs3.60 million shs
Koninklijke Philips stock logo
PHG
Koninklijke Philips
$26.12
-2.0%
$26.62
$19.10
$32.91
$24.55B0.78875,453 shs721,582 shs
Solventum Co. stock logo
SOLV
Solventum
$72.44
-2.1%
$74.37
$47.16
$85.92
$12.53BN/A1.44 million shs936,451 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$107.63
+3.5%
$105.72
$97.69
$133.90
$21.43B1.041.92 million shs2.06 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-2.79%-4.64%-6.41%+0.43%-7.95%
Koninklijke Philips stock logo
PHG
Koninklijke Philips
-2.03%-3.51%-6.62%+1.30%+21.13%
Solventum Co. stock logo
SOLV
Solventum
-2.04%-4.29%-1.54%+4.14%+7,243,699,900.00%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+3.39%+2.25%+8.58%+0.84%-14.97%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
3.3364 of 5 stars
2.43.01.70.03.11.72.5
Koninklijke Philips stock logo
PHG
Koninklijke Philips
2.6032 of 5 stars
0.03.01.70.02.30.03.1
Solventum Co. stock logo
SOLV
Solventum
1.82 of 5 stars
3.02.00.00.03.40.00.0
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.6051 of 5 stars
3.24.01.73.73.12.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.77
Moderate Buy$98.7521.24% Upside
Koninklijke Philips stock logo
PHG
Koninklijke Philips
2.60
Moderate BuyN/AN/A
Solventum Co. stock logo
SOLV
Solventum
2.00
Hold$79.8610.24% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.32
Hold$124.1515.34% Upside

Current Analyst Ratings Breakdown

Latest GEHC, PHG, ZBH, and SOLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/11/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$85.00 ➝ $100.00
3/5/2025
Solventum Co. stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $80.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $82.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$63.00 ➝ $71.00
2/28/2025
Solventum Co. stock logo
SOLV
Solventum
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $75.00
2/28/2025
Solventum Co. stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$75.00 ➝ $84.00
2/26/2025
Solventum Co. stock logo
SOLV
Solventum
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$80.00 ➝ $85.00
2/25/2025
Koninklijke Philips stock logo
PHG
Koninklijke Philips
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform
2/20/2025
Koninklijke Philips stock logo
PHG
Koninklijke Philips
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
2/14/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$96.00 ➝ $103.00
2/13/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$103.00 ➝ $110.00
(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$19.67B1.89$5.11 per share15.94$18.51 per share4.40
Koninklijke Philips stock logo
PHG
Koninklijke Philips
$18.02B1.36$3.23 per share8.08$13.86 per share1.88
Solventum Co. stock logo
SOLV
Solventum
$8.25B1.52N/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.79$13.71 per share7.85$62.67 per share1.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.99B$4.3318.8115.663.1910.13%25.74%6.29%4/29/2025 (Estimated)
Koninklijke Philips stock logo
PHG
Koninklijke Philips
-$503.27M-$0.84N/A13.530.82-3.88%10.85%4.45%5/5/2025 (Estimated)
Solventum Co. stock logo
SOLV
Solventum
N/A$2.7526.3413.191.94N/AN/AN/A5/8/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.4524.1912.131.9511.77%12.99%7.58%5/1/2025 (Estimated)

Latest GEHC, PHG, ZBH, and SOLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/19/2025Q4 2024
Koninklijke Philips stock logo
PHG
Koninklijke Philips
$0.55$0.54-$0.01-$0.38$5.10 billion$5.38 billion
2/13/2025Q4 2024
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.26$1.45+$0.19$1.57$5.33 billion$5.32 billion
2/6/2025Q4 24
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$2.30$2.31+$0.01$1.20$2.01 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.17%N/A3.23%N/A
Koninklijke Philips stock logo
PHG
Koninklijke Philips
$0.752.87%N/AN/A N/A
Solventum Co. stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.89%N/A21.57%N/A

Latest GEHC, PHG, ZBH, and SOLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/24/2025
Koninklijke Philips stock logo
PHG
Koninklijke Philips
annual$0.88602.9%5/13/20255/13/20256/6/2025
2/26/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%3/31/20253/31/20254/30/2025
12/18/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%12/30/202412/30/20241/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.88
1.04
0.83
Koninklijke Philips stock logo
PHG
Koninklijke Philips
0.59
1.23
0.74
Solventum Co. stock logo
SOLV
Solventum
2.45
1.15
0.83
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Koninklijke Philips stock logo
PHG
Koninklijke Philips
13.67%
Solventum Co. stock logo
SOLV
Solventum
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.27%
Koninklijke Philips stock logo
PHG
Koninklijke Philips
N/A
Solventum Co. stock logo
SOLV
Solventum
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
50,000457.30 million456.06 millionOptionable
Koninklijke Philips stock logo
PHG
Koninklijke Philips
78,200939.94 millionN/AOptionable
Solventum Co. stock logo
SOLV
Solventum
22,000172.99 millionN/AOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000199.06 million197.18 millionOptionable

Recent News About These Companies

Zimmer Biomet plans 3 more Rosa robotic indications
Zimmer Biomet Holdings (ZBH) Gets a Hold from Truist Financial
Q3 EPS Estimates for Zimmer Biomet Reduced by Zacks Research
Zacks Research Expects Weaker Earnings for Zimmer Biomet
Zimmer Biomet Holdings, Inc. stock logo
Q3 EPS Estimates for Zimmer Biomet Cut by Zacks Research

New MarketBeat Followers Over Time

Media Sentiment Over Time

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$81.45 -2.34 (-2.79%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$81.90 +0.44 (+0.55%)
As of 03/13/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$26.12 -0.54 (-2.01%)
Closing price 03/13/2025 03:58 PM Eastern
Extended Trading
$26.07 -0.04 (-0.17%)
As of 03/13/2025 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Solventum stock logo

Solventum NYSE:SOLV

$72.44 -1.57 (-2.13%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$72.65 +0.21 (+0.30%)
As of 03/13/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$107.63 +3.60 (+3.46%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$107.50 -0.13 (-0.12%)
As of 03/13/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.